UBS ETF SICAV BBG Barc MSCI US Liq Corp Sust UCITS Hdg To GBP (BSUS)

- Add to watchlist
- Create an alert
- This stock can be held in a




943.50p
950.96p
1,155.20p
London
943.50p
942.60p
935.30p
£828.81M
1.35p (0.14%) Previous:
1.35p
2,090
n/a
GBX
ETP Basics
Issuer: | UBS Asset Management |
---|---|
Structure: | ETF |
Replication method: | Stocks - Full Replication |
Securities lending: | No |
Number of holdings: | 537 |
Size: | £828.8M |
Launch date: | 30 September 2015 |
Launch price: | £10.65 |
UCITS: | Yes |
Reporting status: | Yes |
Domicile: | Luxembourg |
Sophisticated product: | Non-sophisticated |
ISIN: | LU1215461598 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
OBJECTIVE
Index: | Barclays MSCI US Liquid Corporates Sustainable hedged to GBP Total Return |
---|---|
Aim: |
The UBS (Lux) Fund Solutions - Barclays MSCI US Liquid Corporates Sustainable UCITS ETF...
Read full aim for UBS ETF SICAV |
Leverage: | 100% |
Currency hedging: | n/a |
COSTS
Ongoing Charge (OCF/TER): | 0.25% |
---|---|
Management fee: | 0.25% |
Indicative spread: | 0.5% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
Not available for this stock.
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Security | Weight |
---|---|
AbbVie Inc | 0.83% |
Microsoft Corp | 0.83% |
Microsoft Corp | 0.71% |
AbbVie Inc | 0.70% |
Dell International LLC / EMC Corp | 0.62% |
Verizon Communications Inc | 0.59% |
AbbVie Inc | 0.51% |
Bristol-Myers Squibb Co | 0.51% |
JPMorgan Chase & Co | 0.49% |
Citigroup Inc | 0.49% |

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.